Great Point Partners’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.7M Buy
+75,000
New +$12.2M 3.04% 14

Other funds holding BLTE

Great Point Partners's BLTE Position: Q3 2026 in Review

Great Point Partners opened a new position in Belite Bio (BLTE) in Q3 2026: 75,000 shares worth $12.7M. The stake represents 3.04% of the portfolio and ranks #14 among its holdings.

96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Great Point Partners held 75,000 shares of Belite Bio worth $12.7M as of Q3 2026.
  • Belite Bio was a new Great Point Partners position in Q3 2026.
  • Belite Bio made up 3.04% of Great Point Partners's portfolio in Q3 2026, its #14 holding.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Great Point Partners's 13F filing for Q3 2026, filed 16 Nov 2026.